nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer
|
Jiang, Haiping |
|
2015 |
76 |
1 |
p. 197-203 |
artikel |
2 |
A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck
|
Machiels, J.-P. |
|
|
76 |
1 |
p. 13-20 |
artikel |
3 |
A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck
|
Machiels, J.-P. |
|
2015 |
76 |
1 |
p. 13-20 |
artikel |
4 |
A single-dose PK study of onapristone including the effect of food on absorption
|
Rezai, Keyvan |
|
2015 |
76 |
1 |
p. 171-177 |
artikel |
5 |
Association of fludarabine pharmacokinetic/dynamic biomarkers with donor chimerism in nonmyeloablative HCT recipients
|
McCune, Jeannine S. |
|
2015 |
76 |
1 |
p. 85-96 |
artikel |
6 |
Comparison of saliva interleukin-2 concentration to the condition of gums in children with acute lymphoblastic leukaemia during anti-tumour treatment
|
Pels, Elżbieta |
|
2015 |
76 |
1 |
p. 205-210 |
artikel |
7 |
Comparison of the pharmacokinetics of erlotinib administered in complete fasting and 2 h after a meal in patients with lung cancer
|
Katsuya, Yuki |
|
2015 |
76 |
1 |
p. 125-132 |
artikel |
8 |
Correlation between BRCA1 and TopBP1 protein expression and clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy
|
Wang, Lin-run |
|
2015 |
76 |
1 |
p. 163-170 |
artikel |
9 |
Development of a new equation to estimate creatinine clearance in cancer patients
|
Chu, Michael P. |
|
2015 |
76 |
1 |
p. 117-124 |
artikel |
10 |
Direct and indirect targeting of MYC to treat acute myeloid leukemia
|
Brondfield, Sam |
|
2015 |
76 |
1 |
p. 35-46 |
artikel |
11 |
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis
|
Matsuda, Chu |
|
2015 |
76 |
1 |
p. 97-103 |
artikel |
12 |
Effect of bendamustine in combination with rituximab on QT interval duration in patients with advanced de novo indolent non-Hodgkin or mantle cell lymphoma
|
Burke, John M. |
|
|
76 |
1 |
p. 211-216 |
artikel |
13 |
Effect of bendamustine in combination with rituximab on QT interval duration in patients with advanced de novo indolent non-Hodgkin or mantle cell lymphoma
|
Burke, John M. |
|
2015 |
76 |
1 |
p. 211-216 |
artikel |
14 |
Endometrial cancer: redefining the molecular-targeted approach
|
Silva, Jesse Lopes da |
|
2015 |
76 |
1 |
p. 1-11 |
artikel |
15 |
Erratum to: Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study
|
Ozdemir, Nuriye |
|
2015 |
76 |
1 |
p. 217 |
artikel |
16 |
Extension of the Calvert formula to patients with severe renal insufficiency
|
Oguri, Tomoyo |
|
2015 |
76 |
1 |
p. 53-59 |
artikel |
17 |
Gemcitabine plus split-dose cisplatin could be a promising alternative to gemcitabine plus carboplatin for cisplatin-unfit patients with advanced urothelial carcinoma
|
Kim, Yi Rang |
|
2015 |
76 |
1 |
p. 141-153 |
artikel |
18 |
Influence of metastatic disease on the usefulness of uracil pharmacokinetics as a screening tool for DPD activity in colorectal cancer patients
|
Staveren, Maurice C. van |
|
2015 |
76 |
1 |
p. 47-52 |
artikel |
19 |
Inhibition of prostate cancer cell growth by 3′,4′,5′-trimethoxyflavonol (TMFol)
|
Hill, C. U. F. Kelly |
|
2015 |
76 |
1 |
p. 179-185 |
artikel |
20 |
Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial)
|
Kotaka, Masahito |
|
2015 |
76 |
1 |
p. 75-84 |
artikel |
21 |
Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro
|
Cihalova, Daniela |
|
2015 |
76 |
1 |
p. 105-116 |
artikel |
22 |
Pharmacodynamic study of axitinib in patients with advanced malignancies assessed with 18F-3′deoxy-3′fluoro-l-thymidine positron emission tomography/computed tomography
|
Bruce, Justine Yang |
|
2015 |
76 |
1 |
p. 187-195 |
artikel |
23 |
Phase II study of erlotinib in elderly patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations
|
Inoue, Yusuke |
|
2015 |
76 |
1 |
p. 155-161 |
artikel |
24 |
Phase II trial of everolimus in patients with refractory metastatic adenocarcinoma of the esophagus, gastroesophageal junction and stomach: possible role for predictive biomarkers
|
Wainberg, Zev A. |
|
2015 |
76 |
1 |
p. 61-67 |
artikel |
25 |
Pilot study of modified FOLFOX6 adjuvant chemotherapy for high-risk rectal cancer treated with neoadjuvant chemoradiotherapy
|
Lee, Soo Jung |
|
2015 |
76 |
1 |
p. 29-34 |
artikel |
26 |
Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer
|
Nakayama, Izuma |
|
2015 |
76 |
1 |
p. 133-139 |
artikel |
27 |
Sandwich-like neoadjuvant therapy with bevacizumab for locally advanced rectal cancer: a phase II trial
|
Xiao, Jian |
|
2015 |
76 |
1 |
p. 21-27 |
artikel |
28 |
Second-line docetaxel for patients with platinum-refractory advanced non-small cell lung cancer and interstitial pneumonia
|
Watanabe, Naohiro |
|
2015 |
76 |
1 |
p. 69-74 |
artikel |